InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: Waitforit53 post# 29532

Monday, 04/20/2015 5:08:10 PM

Monday, April 20, 2015 5:08:10 PM

Post# of 48316
Exactly. No toxicity, a pain rating of 2 out of 10 (with 10 being the worst) and that too only lasting no more than 5 mins, are other value adds that OncoSec brings to the table along with increasing TILs, responder rate, and systemic response. Just need this Keytruda combo trial to produce good data as expected and OncoSec will be the buzzword in the immunotherapy media coverage.